WeVote
Log In

Bill

Bill

HB 2097

Health insurance; coverage requirements for prostate cancer screenings.

2025 Regular Session Introduced by Terry Austin and 4 co-sponsors

Virginia requires health insurers to cover prostate cancer screenings without cost-sharing, effective July 1, 2025, removing financial barriers but potentially increasing insurance premiums.

Acts of Assembly Chapter text (CHAP0237)
0
WeVote Research Nonpartisan
Bill Summary · HB 2097

Legislative bill overview

HB 2097 requires health insurance plans in Virginia to cover prostate cancer screenings without cost-sharing (copayments, coinsurance, or deductibles). The bill went into effect on July 1, 2025, after receiving Governor's approval in March 2025.

Why is this important

Prostate cancer is the second-most common cancer among men in the U.S., and early detection can improve treatment outcomes. Removing financial barriers to screening may increase testing rates, particularly among underinsured populations. However, this also increases healthcare costs that insurers may pass on to consumers through higher premiums.

Potential points of contention

  • Cost burden: Insurers and employers may argue that mandated free coverage increases premiums for all policyholders, even those who don't use the service
  • Clinical guidelines debate: Medical organizations have varying recommendations on prostate screening ages and frequency; the bill doesn't specify which screening protocols qualify, potentially creating coverage disputes
  • Gender equity concerns: Mandating coverage for prostate cancer screening while other gender-specific cancer screenings may not have similar protections raises fairness questions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.